Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Search
respiratorius
-
search results
If you're not happy with the results, please do another search
Respiratorius’ US patent application reopens
12 April, 2024
In-depth partnering discussions for Respiratorius
15 February, 2024
Arcede aims for clinic with TO1
8 January, 2024
Respiratorius’ CEO: “Strong belief but patience regarding agreement”
17 November, 2023
Respiratorius secures additional patent
17 October, 2023
Respiratorius’ CEO comments on the second quarter
10 August, 2023
Respiratorius continues to strengthen VAL001
3 July, 2023
Respiratorius continues its search for a partner
22 May, 2023
Arcede approaching dosing in tox study
17 May, 2023
Respiratorius’ CEO comments on an eventful year
10 February, 2023
The value of patent protection in life science
14 December, 2022
Watch the BioStock Life Science Fall Summit!
8 December, 2022
Pricing in focus for Respiratorius ahead of partnering discussions
21 November, 2022
Respiratorius marches towards partnering deal
10 November, 2022
Arcede Pharma share under pressure despite development progress
3 November, 2022
Arcede Pharma reports on the first quarter
27 September, 2022
BioStock Investor Meeting: Arcede Pharma presents
22 September, 2022
Positive results from Respiratorius’ PK study
20 September, 2022
BioStock Life Science Fall Summit 2022
16 August, 2022
Arcede wants to renew the market for respiratory drugs
16 August, 2022
Last patient dosed in Respiratorius’ PK study with VAL001
5 July, 2022
Arcede Pharma’s CEO is ready for Spotlight
30 June, 2022
Watch day 2 of the BioStock Life Science Spring Summit
9 June, 2022
The BioStock Life Science Spring Summit starts now
8 June, 2022
New results open up for a broader indication for Respiratorius
1 June, 2022
Focus on company split for Respiratorius during Q4
17 May, 2022
BioStock Life Science Spring Summit, June 8-9, 2022
26 March, 2022
BioStock Investor Meeting 16 March
16 March, 2022
Strong start to 2022 for Respiratorius
18 February, 2022
Respiratorius raises 45 MSEK and prepares COPD project spinoff
11 February, 2022
BioStock Investor Meeting, March 16
27 January, 2022
Respiratorius gets green light for PK study
13 January, 2022
Respiratorius has taken several steps this autumn
15 November, 2021
Join us for the BioStock Life Science Summit on October 20...
20 October, 2021
Respiratorius begins production of VAL001
15 October, 2021
Respiratorius’ RCD405 shows efficacy in preclinical study
13 October, 2021
Respiratorius gets patent approval in Brazil for VAL001
1 October, 2021
Iconovo looks to the US where it now meets quality requirements
24 September, 2021
Patent approved for Respiratorius’ COPD project
1 September, 2021
High expectations on a deal for Respiratorius
3 July, 2021
Respiratorius turns its focus to COPD and severe asthma
3 July, 2021
Eventful stock market journey for Respiratorius in Q3
3 July, 2021
Respiratorius recruits project manager
2 July, 2021
Respiratorius’ CEO looks forward to a new eventful year
2 July, 2021
Respiratorius recruits experienced Clinical Director
2 July, 2021
Respiratorius carries out directed share issue and initiates bridging study with...
2 July, 2021
Respiratorius sees great potential for new COPD treatment
2 July, 2021
Respiratorius looks forward to exciting autumn
29 June, 2021
Innovation in focus at BioStock Life Science Spring Summit 2021
25 May, 2021
Respiratorius and Iconovo collaborate on inhalation product for COPD
21 May, 2021